Page last updated: 2024-08-24

capecitabine and Haim-Monk Syndrome

capecitabine has been researched along with Haim-Monk Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eropkin, PV; Kashnikov, VN; Panina, MV; Rybakov, EG1

Trials

1 trial(s) available for capecitabine and Haim-Monk Syndrome

ArticleYear
[Results of adjuvant chemotherapy (XELOX) of advanced colorectal cancer].
    Voprosy onkologii, 2011, Volume: 57, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Tract; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Oxaloacetates; Papillon-Lefevre Disease; Prospective Studies; Retrospective Studies; Treatment Outcome; Vascular Neoplasms

2011